Found 297 results
Author Keyword [ Title(Asc)] Type Year
Filters: First Letter Of Keyword is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Trias E, Ibarburu S, Barreto-Núñez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, Díaz-Amarilla P, Cassina P et al..  2016.  Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.. J Neuroinflammation. 13(1):177.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.. Anticancer Res. 12(3):885-98.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.. Anticancer Res. 12(3):885-98.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.. Anticancer Res. 12(3):885-98.
Boulikas T.  1992.  Poly(ADP-ribose) synthesis and degradation in mammalian nuclei.. Anal Biochem. 203(2):252-8.
Smith AR, Visioli F, Hagen TM.  2006.  Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age.. Arch Biochem Biophys. 454(1):100-5.
Al-Fageeh M, Li Q, W Dashwood M, Myzak MC, Dashwood RH.  2004.  Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.. Oncogene. 23(28):4839-46.
Legette LC, Ma L, Reed RL, Miranda CL, Christensen JMark, Rodriguez-Proteau R, Stevens JF.  2012.  Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration.. Mol Nutr Food Res. 56(3):466-74.
N
Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.
Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.
Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.
Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.
Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.
Myzak MC, P Karplus A, Chung F-L, Dashwood RH.  2004.  A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase.. Cancer Res. 64(16):5767-74.
Bailey GS, Reddy AP, Pereira CB, Harttig U, Baird W, Spitsbergen JM, Hendricks JD, Orner GA, Williams DE, Swenberg JA.  2009.  Nonlinear cancer response at ultralow dose: a 40800-animal ED(001) tumor and biomarker study.. Chem Res Toxicol. 22(7):1264-76.
Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.
Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.
Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.
Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.
Wang R, Dashwood W-M, Nian H, Löhr CV, Fischer KA, Tsuchiya N, Nakagama H, Ashktorab H, Dashwood RH.  2011.  NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).. Int J Cancer. 128(11):2581-90.
Jump DB.  2008.  N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.. Curr Opin Lipidol. 19(3):242-7.

Pages